These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9676834

  • 1. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
    Brambilla E, Gazzeri S, Lantuejoul S, Coll JL, Moro D, Negoescu A, Brambilla C.
    Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
    [Abstract] [Full Text] [Related]

  • 2. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E.
    Anticancer Res; 1998 Jul; 18(6B):4741-9. PubMed ID: 9891551
    [Abstract] [Full Text] [Related]

  • 3. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
    Jeanmart M, Lantuejoul S, Fievet F, Moro D, Sturm N, Brambilla C, Brambilla E.
    Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
    [Abstract] [Full Text] [Related]

  • 4. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C.
    Clin Cancer Res; 1999 Feb; 5(2):243-50. PubMed ID: 10037171
    [Abstract] [Full Text] [Related]

  • 5. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
    Kalomenidis I, Orphanidou D, Papamichalis G, Vassilakopoulos T, Scorilas A, Rasidakis A, Papastamatiou H, Jordanoglou J, Roussos C.
    Lung; 2001 Feb; 179(5):265-78. PubMed ID: 11976895
    [Abstract] [Full Text] [Related]

  • 6. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N, Takada Y, Hachiya M, Ando K, Nakajima N, Akashi M.
    Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
    [Abstract] [Full Text] [Related]

  • 7. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I, Wyrodek E, Kosacka M, Adamiak J, Jankowska R, Harłozińska-Szmyrka A.
    In Vivo; 2006 Dec; 20(5):599-604. PubMed ID: 17091766
    [Abstract] [Full Text] [Related]

  • 8. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R, Agarwal S, Mathur M, Wasylyk B, Srivastava A.
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [Abstract] [Full Text] [Related]

  • 9. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M, Yokomise H.
    Clin Cancer Res; 2003 Oct 15; 9(13):4926-34. PubMed ID: 14581367
    [Abstract] [Full Text] [Related]

  • 10. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
    Furihata M, Sonobe H, Ohtsuki Y, Yamashita M, Morioka M, Yamamoto A, Terao N, Kuwahara M, Fujisaki N.
    J Pathol; 1996 Feb 15; 178(2):133-9. PubMed ID: 8683378
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL.
    Am J Pathol; 1996 Dec 15; 149(6):1941-52. PubMed ID: 8952529
    [Abstract] [Full Text] [Related]

  • 12. p53 and lung cancer.
    Brambilla E, Brambilla C.
    Pathol Biol (Paris); 1997 Dec 15; 45(10):852-63. PubMed ID: 9769949
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL.
    Cancer Res; 2001 Dec 15; 61(24):8830-7. PubMed ID: 11751405
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of proapoptotic proteins Bax and Bcl-X(S) in p53 overexpressing hepatocellular carcinomas.
    Beerheide W, Tan YJ, Teng E, Ting AE, Jedpiyawongse A, Srivatanakul P.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):54-61. PubMed ID: 10873563
    [Abstract] [Full Text] [Related]

  • 15. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 24; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 16. p53 protein accumulates frequently in early bronchial neoplasia.
    Bennett WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, Metcalf RA, Samet JM, Takeshima Y, Gu JR.
    Cancer Res; 1993 Oct 15; 53(20):4817-22. PubMed ID: 8402667
    [Abstract] [Full Text] [Related]

  • 17. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P, Robey R, Fojo T, Blagosklonny MV.
    Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344
    [Abstract] [Full Text] [Related]

  • 18. p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy.
    Pfister C, Flaman JM, Dunet F, Grise P, Frebourg T.
    J Urol; 1999 Jul 28; 162(1):69-73. PubMed ID: 10379742
    [Abstract] [Full Text] [Related]

  • 19. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 20. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R.
    Cancer Res; 1999 Jun 15; 59(12):2829-33. PubMed ID: 10383141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.